{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:26:45Z","timestamp":1782170805595,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Conselho Nacional de Pesquisa"},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.biopha.2019.109739","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T16:39:45Z","timestamp":1578328785000},"page":"109739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["New 2-amino-pyridinyl-N-acylhydrazones: Synthesis and identification of their mechanism of anti-inflammatory action"],"prefix":"10.1016","volume":"123","author":[{"given":"Natalia de Morais","family":"Cordeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana H.C.N.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto Manssour","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Dias","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2019.109739_bib0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/cyto.2002.0895","article-title":"Transcriptional and posttranscriptional control of gene expression in inflammation","volume":"20","author":"Kracht","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2019.109739_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.cr.7290257","article-title":"Activation and signaling of the p38 MAP kinase pathway","volume":"15","author":"Zarubin","year":"2005","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2019.109739_bib0015","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrd1132","article-title":"Targeting JNK for therapeutic benefit: from junk to gold?","volume":"2","author":"Manning","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2019.109739_bib0020","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","article-title":"NF-kB: linking inflammation and immunity to cancer development and progression","volume":"5","author":"Karin","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2019.109739_bib0025","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.2174\/092986705774462923","article-title":"Therapeutic targets in inflammatory disease","volume":"12","author":"Hume","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2019.109739_bib0030","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrd1177","article-title":"p38 MAP kinases: key signaling molecules as therapeutic targets for inflammatory diseases","volume":"2","author":"Kumar","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2019.109739_bib0035","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.jid.5700701","article-title":"Inflammation in wound repair: molecular and cellular mechanisms","volume":"127","author":"Eming","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2019.109739_bib0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2741\/A171","article-title":"Cytokines in acute and chronic inflammation","volume":"2","author":"Feghali","year":"1997","journal-title":"Front Biosci."},{"key":"10.1016\/j.biopha.2019.109739_bib0045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0898-6568(01)00262-5","article-title":"TNF receptor subtype signalling: differences and cellular consequences","volume":"14","author":"McEwan","year":"2002","journal-title":"Cell. Signal."},{"key":"10.1016\/j.biopha.2019.109739_bib0050","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.4049\/jimmunol.173.11.6928","article-title":"A novel mechanism for TNF-alpha regulation by p38 MAPK: involvement of NF-kappa B with implications for therapy in rheumatoid arthritis","volume":"173","author":"Campbell","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2019.109739_bib0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2249.2009.04033.x","article-title":"Mitogen activated protein kinases: a role in inflammatory bowel disease?","volume":"158","author":"Broom","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.biopha.2019.109739_bib0060","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9703609","article-title":"Fish scale collagen peptides protect against CoCl2\/TNF-\u03b1-induced cytotoxicity and inflammation via inhibition of ROS, MAPK, and NF-\u03baB pathways in HaCaT cells","volume":"2017","author":"Subhan","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2019.109739_bib0065","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1016\/j.bmcl.2018.07.015","article-title":"N-acylhydrazones as drugs","volume":"28","author":"Thota","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2019.109739_bib0070","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2174\/138955707782331722","article-title":"Privileged structures: A useful concept for the rational design of new lead drug candidates","volume":"7","author":"Duarte","year":"2007","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.biopha.2019.109739_bib0075","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.ejmech.2011.01.045","article-title":"Structure-based design and biological profile of (E)-N-(4-Nitrobenzylidene)-2-naphthohydrazide, a novel small molecule inhibitor of I\u03baB kinase-\u03b2","volume":"36","author":"Avila","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2019.109739_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085380","article-title":"Docking, synthesis and antiproliferative activity of N-acylhydrazone derivatives designed as combretastatin A4 analogues","volume":"9","author":"Amaral","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2019.109739_bib0085","doi-asserted-by":"crossref","first-page":"7245","DOI":"10.1021\/jm300514y","article-title":"Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors","volume":"55","author":"K\u00fcmmerle","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2019.109739_bib0090","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/j.1476-5381.2010.00672.x","article-title":"LASSBio-881: an N-acylhydrazone transient receptor potential vanilloid subfamily type 1 antagonist orally effective against the hypernociception induced by capsaicin or partial sciatic ligation","volume":"159","author":"Tributino","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109739_bib0095","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1021\/acs.jmedchem.5b01525","article-title":"Design, synthesis, and pharmacological evaluation of novel n-acylhydrazone derivatives as potent histone deacetylase 6\/8 dual inhibitors","volume":"59","author":"Rodrigues","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2019.109739_bib0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/092986706775197881","article-title":"Medicinal chemistry of N-acylhydrazones: new lead-compounds of analgesic, anti-inflammatory and antithrombotic drugs","volume":"13","author":"Fraga","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biopha.2019.109739_bib0105","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1517\/13543776.2014.959491","article-title":"Acylhydrazone derivatives: a patent review","volume":"24","author":"Maia","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.biopha.2019.109739_bib0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/cbdd.13085","article-title":"Discovery of naphthyl\u2010N\u2010acylhydrazone p38\u03b1 MAPK inhibitors with in vivo anti\u2010inflammatory and anti\u2010TNF\u2010\u03b1 activity","volume":"91","author":"Freitas","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biopha.2019.109739_bib0115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/cmdc.201500266","article-title":"LASSBio-1829 hydrochloride: Development of a new orally activeN-acylhydrazone IKK2 inhibitor with anti-inflammatory properties","volume":"11","author":"Guedes","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.biopha.2019.109739_bib0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0304-3959(87)90088-1","article-title":"The formalin test in mice: dissociation between inflammatory and non-inflammatory pain","volume":"30","author":"Hunskaar","year":"1987","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2019.109739_bib0125","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jep.2006.08.018","article-title":"Antinociceptive activity of amazonian Copaiba oils","volume":"109","author":"Gomes","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2019.109739_bib0130","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jep.2011.01.027","article-title":"Characterisation of the anti-inflammatory and antinociceptive activities of the Hyptis pectinata (L.) Poit essential oil","volume":"134","author":"Raymundo","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2019.109739_bib0135","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ab.2010.07.007","article-title":"Optimization of a nonradioactive immunosorbent assay for p38alpha mitogen-activated protein kinase activity","volume":"406","author":"Goetterta","year":"2010","journal-title":"Biochem. Anal. Biochem."},{"key":"10.1016\/j.biopha.2019.109739_bib0140","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0278-6915(84)90224-2","article-title":"A rapid method for the assay of nitrate in urine using the nitrate reductase enzyme of E. Coli","volume":"22","author":"Bartholomew","year":"1984","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2019.109739_bib0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2019.109739_bib0150","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"22","author":"Denizot","year":"1986","journal-title":"J. Immunol. Met."},{"key":"10.1016\/j.biopha.2019.109739_bib0155","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1021\/cr00039a007","article-title":"Palladium-catalyzed cross-coupling reactions of organoboron compounds","volume":"95","author":"Miyaura","year":"1995","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biopha.2019.109739_bib0160","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1590\/S0103-50532007000700021","article-title":"Pd-catalyzed Suzuki cross-Coupling reaction of bromostilbene: insights on the nature of the boron Species","volume":"18","author":"Nunes","year":"2007","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.biopha.2019.109739_bib0165","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0223-5234(00)00120-3","article-title":"Synthesis and analgesic activity of novel N-acylarylhydrazones and isosters, derived from natural safrole","volume":"35","author":"Lima","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2019.109739_bib0170","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1016\/S0040-4020(01)87332-4","article-title":"Conformational behaviour and E\/Z isomerization of N-acyl and N-aroylhydrazones","volume":"42","author":"Palla","year":"1986","journal-title":"Tetrahedron"},{"key":"10.1016\/j.biopha.2019.109739_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156271","article-title":"Discovery of novel orally active tetrahydro-naphthyl-n-acylhydrazones with in vivo anti-TNF-\u03b1 effect and remarkable anti-inflammatory properties","volume":"11","author":"Cordeiro","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2019.109739_bib0180","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/00032719808001874","article-title":"Diastereomeric analysis of bioactive N-Phenylpyrazole-4-acylhydrazone derivatives by high resolution gas chromatography","volume":"31","author":"Pereira","year":"1998","journal-title":"Anal. Lett."},{"key":"10.1016\/j.biopha.2019.109739_bib0185","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1016\/j.bmc.2009.08.009","article-title":"Synthesis and analgesic profile of conformationally constrained N-acylhydrazone analogues: discovery of novel N-arylideneamino quinazolin-4(3H)-one compounds derived from natural safrole","volume":"17","author":"Maia","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2019.109739_bib0190","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0022-3565(24)34942-0","article-title":"SB 203580, an inhibitor of p38 mitogen-activated protein kinase, enhances constitutive apoptosis of cytokine-deprived human eosinophils","volume":"290","author":"Kankaanranta","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2019.109739_bib0195","doi-asserted-by":"crossref","first-page":"25883","DOI":"10.1074\/jbc.M000296200","article-title":"Characterization of the Recombinant IKK1\/IKK2 Heterodimer: mechanisms regulating kinase activity","volume":"275","author":"Huynh","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2019.109739_bib0200","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109739_bib0205","article-title":"Drug solubility: importance and enhancement techniques","volume":"2012","author":"Savjani","year":"2012","journal-title":"ISRN Pharm."},{"key":"10.1016\/j.biopha.2019.109739_bib0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.phytol.2008.12.004","article-title":"Rapid solubility determination of the triterpenes oleanolic acid and ursolic acid by UV-spectroscopy in different solvents","volume":"2","author":"Schneider","year":"2009","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.biopha.2019.109739_bib0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5313\/wja.v3.i1.71","article-title":"Molecular mechanism of inflammatory pain","volume":"3","author":"Su","year":"2014","journal-title":"World J. Anesthesiol."},{"key":"10.1016\/j.biopha.2019.109739_bib0220","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.bjp.0704851","article-title":"Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test","volume":"137","author":"Yamamoto","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2019.109739_bib0225","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0968-0004(00)01595-4","article-title":"p38 MAP kinases: beyond the stress response","volume":"25","author":"Nebreda","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2019.109739_bib0230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method","volume":"51","author":"Tj\u00f8lsen","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2019.109739_bib0235","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1152\/ajprenal.00393.2016","article-title":"Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-\u03baB-TNF-\u03b1 and TGF-\u03b21-MAPK-fibronectin pathways","volume":"313","author":"Malik","year":"2017","journal-title":"American J. Physiol.-Renal Physiol."},{"key":"10.1016\/j.biopha.2019.109739_bib0240","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10495-015-1152-y","article-title":"Berberine prevents nitric oxide-induced rat chondrocyte apoptosis and cartilage degeneration in a rat osteoarthritis model via AMPK and p38 MAPK signaling","volume":"20","author":"Zhou","year":"2015","journal-title":"Apoptosis."},{"key":"10.1016\/j.biopha.2019.109739_bib0245","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/10715762.2013.845295","article-title":"Melatonin suppresses nitric oxide production in glial cultures by pro-inflammatory cytokines through p38 MAPK inhibition","volume":"48","author":"Vilar","year":"2014","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.biopha.2019.109739_bib0250","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1302\/2046-3758.76.BJR-2017-0138.R1","article-title":"Inhibition of miR-126 protects chondrocytes from IL-1\u03b2 induced inflammation via upregulation of Bcl-2","volume":"7","author":"Yu","year":"2018","journal-title":"Bone Joint Res."},{"key":"10.1016\/j.biopha.2019.109739_bib0255","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.intimp.2014.04.004","article-title":"Geniposide suppresses LPS-induced nitric oxide, PGE2 and inflammatory cytokine by downregulating NF-\u03baB, MAPK and AP-1 signaling pathways in macrophages","volume":"20","author":"Shi","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2019.109739_bib0260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.taap.2015.06.012","article-title":"Reactive oxygen species mediate nitric oxide production through ERK\/JNK MAPK signaling in HAPI microglia after PFOS exposure","volume":"288","author":"Wang","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219353612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332219353612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:53:09Z","timestamp":1760097189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332219353612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":52,"alternative-id":["S0753332219353612"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109739","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New 2-amino-pyridinyl-N-acylhydrazones: Synthesis and identification of their mechanism of anti-inflammatory action","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2019.109739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"109739"}}